NCT07534813 2026-04-16
A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors
Grit Biotechnology
Phase NA Not yet recruiting
Clinical Trials
19 trialsNCT07492173 2026-03-25
Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans
Shandong New Time Pharmaceutical Co., LTD
Phase NA Completed
NCT06658951 2026-03-19
Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
Phase NA Recruiting
NCT07137195 2026-02-27
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)
Ion Beam Applications
Phase NA Active not recruiting
NCT06397963 2026-01-26
Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours
Grit Biotechnology
Phase NA Recruiting
NCT07153094 2026-01-16
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)
Ion Beam Applications
Phase NA Active not recruiting
NCT07152353 2026-01-07
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)
Ion Beam Applications
Phase NA Active not recruiting
NCT07185243 2025-09-22
A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors.
Hangzhou Converd Co., Ltd.
Phase NA Recruiting
NCT07152236 2025-09-03
Clinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors
Guangzhou Bio-gene Technology Co., Ltd
Phase NA Recruiting
NCT06889675 2025-03-21
First in Human Study of YB1-X7 Injection
Shanghai Salvectors Biotechnology LTD.
Phase NA Not yet recruiting
NCT06145802 2025-02-17
Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (gynecological Tumors)
Grit Biotechnology
Phase NA Recruiting
NCT00828919 2024-12-03
Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials
Pfizer
Phase NA Completed
NCT06245018 2024-02-07
A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor
Nuwacell Biotechnologies Co., Ltd.
Phase NA Not yet recruiting
NCT05949775 2023-07-18
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Stemirna Therapeutics
Phase NA Unknown
NCT04691713 2020-12-31
CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase NA Unknown
NCT03998345 2020-09-09
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase NA Unknown
NCT01369433 2020-09-01
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
AVEO Pharmaceuticals, Inc.
Phase NA Terminated
NCT00748085 2015-07-23
ICEtheMAD
CSA Medical, Inc.
Phase NA Terminated
NCT00798889 2013-01-21
Rollover Protocol for Prior SU011248 Protocols
Pfizer
Phase NA Completed